| 175.89 Delayed Data As of 4:15pm ET |  -2.50 / -1.40%Today’s Change | 166.30 Today|||52-Week Range 210.19 | -9.65% Year-to-Date |
| Previous close | 178.39 |
| Today’s open | 177.83 |
| Day’s range | 175.72 - 178.81 |
| Volume | 2,556,793 |
| Average volume (3 months) | 2,815,710 |
| Market cap | $108.8B |
| Earnings growth (last year) | +368.59% |
| Earnings growth (this year) | -2.90% |
| Earnings growth (next 5 years) | +6.00% |
| Revenue growth (last year) | +4.32% |
| P/E ratio | 14.0 |
| Price/Sales | 5.45 |
| Price/Book | 8.99 |
| Today’s change | Today’s % change | |
|---|---|---|
| GILDGilead Sciences | -0.13 | -0.20% |
| BIIBBiogen | +1.21 | +0.52% |
| ILMNIllumina Inc | +5.08 | +1.73% |
| EXASExact Sciences Corp | +1.17 | +1.02% |
| Next reporting date | July 30, 2019 |
| EPS forecast (this quarter) | $3.60 |
| Annual revenue (last year) | $23.8B |
| Annual profit (last year) | $8.4B |
| Net profit margin | 35.32% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Robert A. Bradway |
Executive Vice President- Operations Esteban Santos |
Corporate headquarters Thousand Oaks, California |
